Phase
Condition
Colic
Gastrointestinal Diseases And Disorders
Lactose Intolerance
Treatment
digestive enzymes
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Provision of written informed consent.
Commitment to availability throughout the study period.
Patients who fulfilled the Rome IV criteria for IBS (IBS-D, IBS-M, IBS-U)participated in the two-arm clinical trial (ClinicalTrials.gov ID: NCT03997708) asresponders to the Mediterranean Diet Adjusted to Low FODMAP (MED-LFD) (if theirsymptoms recurred -with IBS-SSS > 175- one year after their initial response to thedietary intervention).
Subjects randomized to the MED-LFD arm of the previous study who could not adhere tothe dietary intervention.
Exclusion
Exclusion Criteria:
Patients who did not take part in the aforementioned study
Patients who were randomized in the NICE group
Patients with IBS-SSS<175.
Study Design
Study Description
Connect with a study center
Attikon University General Hospital
Chaïdári, Athens
GreeceActive - Recruiting
Attikon University General Hospital
Athens, 12462
GreeceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.